Skip to content
★ Sign in to follow
HC

Harold C. Flynn Jr.

Biolase, Inc
Total declarations
10
Company
1
▲ Purchases (4 ops.)
€36k
▼ Sales (0 ops.)
—

Latest filing published 06 Dec 2017 for BIOLASE, INC, €25k.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Harold C. Flynn Jr.: trading record in brief

Harold C. Flynn Jr. appears in our data through filings on Biolase, Inc shares, published by SEC (Form 4). Over a trading history stretching from 9 November 2015 to 5 December 2017, the count stands at 10 filings.

The open-market record is one-sided, with 4 purchases worth €36k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 2 option exercises.

Half of the purchases are above €7,862 and half below.

Most recently, on 6 December 2017, the filings show a share grant worth €25k in Biolase, Inc. The most recent open-market purchase was published on 12 November 2015, 4,015 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Harold C. Flynn Jr.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ◆
    President and CEOExecutivesBiolase, Inc
    30,037 USD24SEC
    65,870 shares@ US$0.45623.3% of flowCommon StockSEC:0001209191-17-064129:0
  • ●
    President and CEOExecutivesBiolase, Inc
    38,068 USD25SEC
    30,700 shares@ US$1.2430.7% of flowCommon StockSEC:0001209191-17-042885:0
  • ◇
    President and CEOExecutivesBiolase, Inc
    0SEC
    29,761 sharesCommon StockSEC:0000905148-17-000429:0
  • ●
    President and CEOExecutivesBiolase, Inc
    40,002 USD25SEC
    35,400 shares@ US$1.1332.9% of flowCommon StockSEC:0001209191-16-144514:0
  • ◇
    President and CEOExecutivesBiolase, Inc
    0SEC
    29,762 sharesCommon StockSEC:0000899243-16-017483:0
  • ◆
    President and CEOExecutivesBiolase, Inc
    16,132 USD23SEC
    12,803 shares@ US$1.2613.1% of flowCommon StockSEC:0000899243-16-017483:1
  • ▲
    President and CEOExecutivesBiolase, Inc
    7,200 USD0SEC
    10,000 shares@ US$0.72Common Stock, par value $0.001 per shareSEC:0001209191-15-079776:0
    Canonical exit: 7 Feb 2016 (T+90)
  • ▲
    President and CEOExecutivesBiolase, Inc
    9,677 USD0SEC
    12,567 shares@ US$0.77Common Stock, par value $0.001 per shareSEC:0001209191-15-079776:1
    Canonical exit: 7 Feb 2016 (T+90)
  • ▲
    President and CEOExecutivesBiolase, Inc
    4,160 USD0SEC
    5,333 shares@ US$0.78Common Stock, par value $0.001 per shareSEC:0001209191-15-079776:2
    Canonical exit: 7 Feb 2016 (T+90)
  • ▲
    President and CEOExecutivesBiolase, Inc
    17,680 USD0SEC
    22,100 shares@ US$0.80Common Stock, par value $0.001 per shareSEC:0001209191-15-079776:3
    Canonical exit: 7 Feb 2016 (T+90)

10 of 10 declarations